Jude Onyia has not been actively trading shares of Neurocrine Biosciences in the last ninety days. Most recently, Jude Onyia sold 2,331 shares of the business's stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $113.57, for a transaction totalling $264,731.67. Following the completion of the sale, the insider now directly owns 11,732 shares of the company's stock, valued at $1,332,403.24. Learn More on Jude Onyia's trading history.